Reliability and Validity of the Iranian Version of the Pediatric Quality of Life Inventory™ 4.0 Generic Core Scales in Adolescents
Overview
Rehabilitation Medicine
Authors
Affiliations
Objective: The objective of this study was to investigate the reliability and validity of the Iranian version of the Pediatric Quality of Life Inventory™ 4.0 (PedsQL™ 4.0) Generic Core Scales in adolescents
Methods: After linguistic validation, the Iranian version of the PedsQL™ 4.0 was completed by 848 healthy and 26 chronically ill adolescents aged 13-18 years and their parents.
Results: The internal consistency as measured by Cronbach's alpha coefficients exceeded the minimum reliability standard of .70. No floor effects were observed. Ceiling effects detected ranged from 1.5% for adolescent self-report total scale score to 42.2% for self-report social functioning. All monotrait-multimethod correlations were higher than multitrait-multimethod correlations. The intraclass correlation coefficients (ICC) between adolescent self-report and parent proxy-report showed good to excellent agreement. Exploratory factor analysis supported mainly comparable results with the original US English dialect version. The results of the confirmatory factor analysis for 5-factor models for both self-report and proxy-report indicated acceptable fit for the proposed models. Regarding gender and health status, as hypothesized from previous studies, girls reported lower health-related quality of life than boys on the total score, physical and emotional functioning, and healthy adolescents reported significantly higher health-related quality of life than those with chronic illnesses.
Conclusion: The findings support the initial reliability and validity of the Iranian version of the PedsQL™ 4.0 as a generic instrument to measure HRQOL of adolescents in Iran.
Jalali-Farahani S, Zayeri F, Zarani F, Azizi F, Amiri P Int J Endocrinol Metab. 2022; 20(2):e123237.
PMID: 35993035 PMC: 9375937. DOI: 10.5812/ijem-123237.
Sato I, Soejima T, Ikeda M, Kobayashi K, Setoyama A, Kamibeppu K J Patient Rep Outcomes. 2022; 6(1):10.
PMID: 35092532 PMC: 8800985. DOI: 10.1186/s41687-022-00416-3.
Parvin P, Amiri P, Jalali-Farahani S, Karimi M, Moein Eslam M, Azizi F Int J Endocrinol Metab. 2022; 19(4):e113107.
PMID: 35069749 PMC: 8762283. DOI: 10.5812/ijem.113107.
Cognitive behavioral therapy combined with "empathy nursing" model on recurrent depressive disorder.
Zheng Z, Huang J Am J Transl Res. 2021; 13(11):12816-12824.
PMID: 34956496 PMC: 8661196.
de Bruyne E, Eloot S, Walle J, Raes A, Van Biesen W, Goubert L Pediatr Nephrol. 2021; 37(5):1087-1096.
PMID: 34599378 DOI: 10.1007/s00467-021-05224-3.